To establish the relevance of our findings to human settings, we used humanized mice expressing HLA-II DR3 or DR4 as preclinical subcutaneous infection models of GAS NSTI with no apparent lethal systemic toxicity [12,28,47]. Here, TNFRSF10A is linked to infection.